Hodgkin disease: pharmacologic intervention of the CD40-NF kappa B pathway by a protease inhibitor.

Abstract:

:The malignant Reed-Sternberg cell of Hodgkin disease is an aberrant B cell that persists in an immunolgically mediated inflammatory infiltrate. Despite its nonproductive immunoglobulin genes, the Reed-Sternberg cell avoids the usual apoptotic fate of defective immune cells through an unknown mechanism. A likely candidate is the surface receptor, CD40, consistently expressed by Reed-Sternberg cells, and the first link in the pathway to NF-kappa B activation, the central regulator of cytokine production and apoptosis. CD40 signaling in B lymphocytes coordinates the immune response, including immunoglobulin isotype switch and Fas-mediated apoptosis. CD40-induced NF-kappa B activation is mediated by adapter proteins, the TNF receptor (TNFR)-associated factors (TRAFs), especially TRAFs 2, 3, and 5. Using a Hodgkin cell line, this study demonstrates that CD40 activation of NF-kappa B is mediated by proteolysis of TRAF3. Results further demonstrate that the pathway can be blocked by treatment with pharmacologic doses of a specific protease inhibitor, pepstatin-A, even in the presence of a mutated NF-kappa B inhibitor, I-kappa B alpha. The stability of TRAF3 regulates CD40/NF-kappa B-mediated control of the immune response, which is central to the biologic activity of the Reed-Sternberg cell. Prevention of TRAF3 proteolysis may be an entry point for design of novel pharmaceuticals to treat Hodgkin disease and immune system disorders. (Blood. 2000;96:2841-2848)

journal_name

Blood

journal_title

Blood

authors

Annunziata CM,Safiran YJ,Irving SG,Kasid UN,Cossman J

subject

Has Abstract

pub_date

2000-10-15 00:00:00

pages

2841-8

issue

8

eissn

0006-4971

issn

1528-0020

journal_volume

96

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Programming tumor-reactive effector memory CD8+ T cells in vitro obviates the requirement for in vivo vaccination.

    abstract::Naive and memory CD8(+) T cells can undergo programmed activation and expansion in response to a short T-cell receptor stimulus, but the extent to which in vitro programming can qualitatively substitute for an in vivo antigen stimulation remains unknown. We show that self-/tumor-reactive effector memory CD8(+) T cells...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-12-192419

    authors: Klebanoff CA,Yu Z,Hwang LN,Palmer DC,Gattinoni L,Restifo NP

    更新日期:2009-08-27 00:00:00

  • The inherited diseases of hemoglobin are an emerging global health burden.

    abstract::It is estimated that in excess of 300,000 children are born each year with a severe inherited disorder of hemoglobin and that approximately 80% of these births occur in low- or middle-income countries. As these countries go through an epidemiologic transition, with a reduction in childhood and infant mortality due to ...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2010-01-251348

    authors: Weatherall DJ

    更新日期:2010-06-03 00:00:00

  • Reversing anti-factor Xa agents and the unmet needs in trauma patients.

    abstract::Andexanet alfa, a reversing agent for anticoagulants that inhibit factor Xa, has recently been licensed in the United States. We discuss the impact of this licensure on current practice and review in detail the problems of a neglected and growing clinical area: reversing the anticoagulation effect of factor Xa inhibit...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2018-06-850396

    authors: Hunt BJ,Neal MD,Stensballe J

    更新日期:2018-12-06 00:00:00

  • Structural, functional, and tissue distribution analysis of human transferrin receptor-2 by murine monoclonal antibodies and a polyclonal antiserum.

    abstract::Human transferrin receptor-2 (TFR-2) is a protein highly homologous to TFR-1/CD71 and is endowed with the ability to bind transferrin (TF) with low affinity. High levels of TFR-2 mRNA were found in the liver and in erythroid precursors. Mutations affecting the TFR-2 gene led to hemochromatosis type 3, a form of inheri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0076

    authors: Deaglio S,Capobianco A,Calì A,Bellora F,Alberti F,Righi L,Sapino A,Camaschella C,Malavasi F

    更新日期:2002-11-15 00:00:00

  • Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.

    abstract::B-lymphoid kinase (Blk) is exclusively expressed in B cells and thymocytes. Interestingly, transgenic expression of a constitutively active form of Blk in the T-cell lineage of mice results in the development of T-lymphoid lymphomas. Here, we demonstrate nuclear factor-kappa B (NF-kappaB)-mediated ectopic expression o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-181024

    authors: Krejsgaard T,Vetter-Kauczok CS,Woetmann A,Kneitz H,Eriksen KW,Lovato P,Zhang Q,Wasik MA,Geisler C,Ralfkiaer E,Becker JC,Ødum N

    更新日期:2009-06-04 00:00:00

  • The presence of novel amino acids in the cytoplasmic domain of stem cell factor results in hematopoietic defects in Steel(17H) mice.

    abstract::Stem cell factor (SCF) is expressed as an integral membrane growth factor that may be differentially processed to produce predominantly soluble (S) (SCF(248)) or membrane-associated (MA) (SCF(220)) protein. A critical role for membrane presentation of SCF in the hematopoietic microenvironment (HM) has been suggested f...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kapur R,Cooper R,Xiao X,Weiss MJ,Donovan P,Williams DA

    更新日期:1999-09-15 00:00:00

  • Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.

    abstract::Recently various genetic defects in immunity mediated by interferon gamma (IFN-gamma) have been described, including mutations in the IFN-gamma receptor 1 (IFN-gammaR1) and receptor 2 (IFN-gammaR2), signal transducer and activator of transcription 1 (STAT 1), and interleukin 12 receptor beta 1 (IL-12Rbeta1), and IL-12...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1065

    authors: Höflich C,Sabat R,Rosseau S,Temmesfeld B,Slevogt H,Döcke WD,Grütz G,Meisel C,Halle E,Göbel UB,Volk HD,Suttorp N

    更新日期:2004-01-15 00:00:00

  • Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial.

    abstract::Leukemia relapse is a major cause of treatment failure for patients with acute leukemia given allogeneic bone marrow transplantation (BMT). This study evaluated whether a reduction of the dosage of cyclosporine-A (Cs-A) used for graft versus host disease (GVHD) prophylaxis could reduce relapse rate (RR) in children wi...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:

    authors: Locatelli F,Zecca M,Rondelli R,Bonetti F,Dini G,Prete A,Messina C,Uderzo C,Ripaldi M,Porta F,Giorgiani G,Giraldi E,Pession A

    更新日期:2000-03-01 00:00:00

  • Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.

    abstract::Ferroportin (FPN), the only known vertebrate iron exporter, transports iron from intestinal, splenic, and hepatic cells into the blood to provide iron to other tissues and cells in vivo. Most of the circulating iron is consumed by erythroid cells to synthesize hemoglobin. Here we found that erythroid cells not only co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-04-842997

    authors: Zhang DL,Ghosh MC,Ollivierre H,Li Y,Rouault TA

    更新日期:2018-11-08 00:00:00

  • Expansion of EBNA1-specific effector T cells in posttransplantation lymphoproliferative disorders.

    abstract::Immunosuppression resulting in impaired Epstein-Barr virus (EBV)-specific T-cell immunity is involved in the pathogenesis of EBV-positive post-transplantation lymphoproliferative disorder (EBV(+) PTLD). Restoration of EBV-specific T-cell immunity by adoptive immunotherapy can induce remission. EBV-nuclear antigen-1 (E...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-03-274076

    authors: Jones K,Nourse JP,Morrison L,Nguyen-Van D,Moss DJ,Burrows SR,Gandhi MK

    更新日期:2010-09-30 00:00:00

  • T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis.

    abstract::T-cell receptor (TCR) beta-chain proteins appear early (approximately 15th week of gestation) during human thymic ontogenesis. These beta-chain proteins, which appear before terminal deoxynucleotidyl transferase (TdT), could be an expression of a fully rearranged (V-D-J), incompletely rearranged (D-J), or germline TCR...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bonati A,Zanelli P,Ferrari S,Plebani A,Starcich B,Savi M,Neri TM

    更新日期:1992-03-15 00:00:00

  • SLFN11 promotes stalled fork degradation that underlies the phenotype in Fanconi anemia cells.

    abstract::Fanconi anemia (FA) is a hereditary disorder caused by mutations in any 1 of 22 FA genes. The disease is characterized by hypersensitivity to interstrand crosslink (ICL) inducers such as mitomycin C (MMC). In addition to promoting ICL repair, FA proteins such as RAD51, BRCA2, or FANCD2 protect stalled replication fork...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019003782

    authors: Okamoto Y,Abe M,Mu A,Tempaku Y,Rogers CB,Mochizuki AL,Katsuki Y,Kanemaki MT,Takaori-Kondo A,Sobeck AT,Bielinsky AK,Takata M

    更新日期:2020-07-31 00:00:00

  • Activation of the CPP32 protease in apoptosis induced by 1-beta-D-arabinofuranosylcytosine and other DNA-damaging agents.

    abstract::The response of human myeloid leukemia cells to treatment with 1-beta-arabinofuranosylcytosine (ara-C) includes the induction of apoptosis. Ara-C induced apoptosis is associated with proteolytic cleavage of poly(ADP-ribose) polymerase (PARP) and protein kinase C (PKC) delta. However, the signals involved in this respo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Datta R,Banach D,Kojima H,Talanian RV,Alnemri ES,Wong WW,Kufe DW

    更新日期:1996-09-15 00:00:00

  • Cytosolic phospholipase A2 type IVA is present in human red cells.

    abstract::Phospholipase A(2) type IVA (IVAPLA(2)) is a cytosolic enzyme that on activation selectively releases arachidonic acid (AA) from cell membrane phospholipids. Both AA and lysophospholipid, products of the enzymic reaction, can function as signal transducers in cellular interactions. The enzyme is present in most cells,...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-09-2698

    authors: Macdonald DJ,Boyle RM,Glen AC,Horrobin DF

    更新日期:2004-05-01 00:00:00

  • A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia.

    abstract::This phase 2 study evaluated the efficacy and safety of the oral farnesyltransferase inhibitor tipifarnib in adults with refractory or relapsed acute myeloid leukemia (AML). Patients (n=252) received tipifarnib 600 mg twice a day for 21 days in 28-day cycles. Median age was 62 years; 99 (39%) patients were 65 years or...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-046144

    authors: Harousseau JL,Lancet JE,Reiffers J,Lowenberg B,Thomas X,Huguet F,Fenaux P,Zhang S,Rackoff W,De Porre P,Stone R,Farnesyltransferase Inhibition Global Human Trials (FIGHT) Acute Myeloid Leukemia Study Group.

    更新日期:2007-06-15 00:00:00

  • A unique precipitating autoantibody against plasma thromboplastin antecedent associated with multiple apparent plasma clotting factor deficiencies in a patient with systemic lupus erythematosus.

    abstract::A 42-yr-old woman with systemic lupus erythematosus without bleeding diathesis developed a prolonged activated partial thromboplastin time that was not corrected by normal plasma. An inhibitor that acted rapidly and inactivated 0.5 U/ml plasma thromboplastin antecedent (PTA, factor XI) at a 1:200 plasma dilution was d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Poon MC,Saito H,Koopman WJ

    更新日期:1984-06-01 00:00:00

  • Enhancement of the biologic effects of interleukin-3 in vivo by anti-interleukin-3 antibodies.

    abstract::Interleukin-3 (IL-3) has been shown to be a promising agent in the stimulation of bone marrow regeneration following myeloablative therapy. The biologic half-life of this agent is very short (5 to 15 minutes), which limits the effectiveness of low-dose therapy. Here we show that the biologic effects of low-dose IL-3 i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jones AT,Ziltener HJ

    更新日期:1993-08-15 00:00:00

  • Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDS.

    abstract::Wilms' tumor 1 (WT1) is constantly expressed in leukemic cells of acute leukemia and myelodysplastic syndrome (MDS). A T-cell receptor (TCR) that specifically reacts with WT1 peptide in the context of HLA-A*24:02 has been identified. We conducted a first-in-human trial of TCR-gene transduced T-cell (TCR-T-cell) transf...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-791202

    authors: Tawara I,Kageyama S,Miyahara Y,Fujiwara H,Nishida T,Akatsuka Y,Ikeda H,Tanimoto K,Terakura S,Murata M,Inaguma Y,Masuya M,Inoue N,Kidokoro T,Okamoto S,Tomura D,Chono H,Nukaya I,Mineno J,Naoe T,Emi N,Yasukawa M,

    更新日期:2017-11-02 00:00:00

  • Production of laminin B2 chain protein and messenger RNA by a murine neutrophil precursor cell line, 32Dc13.

    abstract::Laminin is a heterotrimeric glycoprotein that plays a central role in promoting neutrophil chemotaxis, motility, and attachment to basement membrane. Rabbit peritoneal exudate neutrophils stain positively for laminin, which is presumed to be of exogenous origin and bound to laminin receptors on the cell surface. We ex...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tweardy DJ,Sasaki M,Cardamone JJ Jr,McCoy JP Jr,Bonidie MJ,Signorella AP

    更新日期:1990-10-01 00:00:00

  • Accelerated telomere shortening in glycosylphosphatidylinositol (GPI)-negative compared with GPI-positive granulocytes from patients with paroxysmal nocturnal hemoglobinuria (PNH) detected by proaerolysin flow-FISH.

    abstract::Telomere length has been linked to disease stage and degree of (pan-)cytopenia in patients with bone marrow failure syndromes. The aim of the current study was to analyze the impact of replicative stress on telomere length in residual glycosylphosphatidylinositol-positive (GPI+) versus GPI- hematopoiesis in patients w...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-10-3996

    authors: Beier F,Balabanov S,Buckley T,Dietz K,Hartmann U,Rojewski M,Kanz L,Schrezenmeier H,Brümmendorf TH

    更新日期:2005-07-15 00:00:00

  • Functional divergence between 2 chemokines is conferred by single amino acid change.

    abstract::CXCL4 and CXCL4L1 are 2 closely related CXC chemokines that exhibit potent antiangiogenic activity. Because interactions with glycosaminoglycans play a crucial role in chemokines activity, we determined the binding parameters of CXCL4 and CXCL4L1 for heparin, heparan sulfate, and chondroitin sulfate B. We further demo...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-03-274852

    authors: Dubrac A,Quemener C,Lacazette E,Lopez F,Zanibellato C,Wu WG,Bikfalvi A,Prats H

    更新日期:2010-11-25 00:00:00

  • Aggregation of hemoglobin S and hemoglobin CHarlem with nonsickle hemoglobin in concentrated phosphate buffer.

    abstract::The effect of HbA and HbF on both the aggregation and deaggregation of deoxy HbS and deoxy HbCHarlem in concentrated phosphate buffers was studied by a turbidimetric method. Although pure deoxy HbA is fully soluble in 2.4 M potassium phosphate buffer, the same concentration of deoxy HbAS was insoluble in the same buff...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Adachi K,Asakura T,Schwartz E

    更新日期:1980-03-01 00:00:00

  • Retinoid signaling regulates primitive (yolk sac) hematopoiesis.

    abstract::It is known from nutritional studies that vitamin A is an important factor for normal hematopoiesis, though it has been difficult to define its precise role. The vitamin A-deficient (VAD) quail embryo provides an effective ligand "knockout" model for investigating the function of retinoids during development. The VAD ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.7.2379

    authors: Ghatpande S,Ghatpande A,Sher J,Zile MH,Evans T

    更新日期:2002-04-01 00:00:00

  • Erythrocyte deformation in shear flow: influences of internal viscosity, membrane stiffness, and hematocrit.

    abstract::The effect of shear force (depending on shear rate and viscosity of extracellular medium) and hematocrit of RBC suspension on RBC deformation was studied quantitatively using a cone-plate rheoscope with various kinds of cells, ie, partially hemolyzed (PH) cells, density-fractionated intact cells, and diamide-treated c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kon K,Maeda N,Shiga T

    更新日期:1987-03-01 00:00:00

  • Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells.

    abstract::We previously found that the myeloid cell surface glycoprotein CD13 (gp150) is identical to aminopeptidase N (EC 3.4.11.2), a widely distributed membrane-bound, zinc-dependent metalloprotease with an extracellular enzymatic domain that cleaves N-terminal amino acid residues from oligopeptides (J Clin Invest 83:1299, 1...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ashmun RA,Look AT

    更新日期:1990-01-15 00:00:00

  • IL8-CXCR2 pathway inhibition as a therapeutic strategy against MDS and AML stem cells.

    abstract::Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are associated with disease-initiating stem cells that are not eliminated by conventional therapies. Novel therapeutic targets against preleukemic stem cells need to be identified for potentially curative strategies. We conducted parallel transcriptional...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-01-621631

    authors: Schinke C,Giricz O,Li W,Shastri A,Gordon S,Barreyro L,Bhagat T,Bhattacharyya S,Ramachandra N,Bartenstein M,Pellagatti A,Boultwood J,Wickrema A,Yu Y,Will B,Wei S,Steidl U,Verma A

    更新日期:2015-05-14 00:00:00

  • Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells.

    abstract::Activation of the mitogen-activated protein (MAP) kinase pathway has been associated with both cell proliferation and differentiation. Constitutively activated forms of Mek (MAP kinase/Erk kinase) and Erk (MAP kinase) have been previously shown capable of inducing differentiation or proliferation in nonhematopoietic c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Melemed AS,Ryder JW,Vik TA

    更新日期:1997-11-01 00:00:00

  • Treatment with interleukin-3 plus granulocyte-macrophage colony-stimulating factors improves the selectivity of Ara-C in vitro against acute myeloid leukemia blasts.

    abstract::Hematopoietic growth factors (HGFs) interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) individually have been shown to increase the percentage of acute myeloid leukemia (AML) blasts in S phase and enhance the cytotoxic effects of Ara-C against these blasts in culture. We compared in vit...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Bhalla K,Holladay C,Arlin Z,Grant S,Ibrado AM,Jasiok M

    更新日期:1991-11-15 00:00:00

  • Caloric restriction modulates Mcl-1 expression and sensitizes lymphomas to BH3 mimetic in mice.

    abstract::Caloric restriction (CR) is proposed to decrease tumorigenesis through a variety of mechanisms including effects on glycolysis. However, the understanding of how CR affects the response to cancer therapy is still rudimentary. Here, using the Eµ-Myc transgenic mouse model of B-cell lymphoma, we report that by reducing ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-01-478651

    authors: Meynet O,Zunino B,Happo L,Pradelli LA,Chiche J,Jacquin MA,Mondragón L,Tanti JF,Taillan B,Garnier G,Reverso-Meinietti J,Mounier N,Michiels JF,Michalak EM,Carles M,Scott CL,Ricci JE

    更新日期:2013-10-03 00:00:00

  • Organ-derived dendritic cells have differential effects on alloreactive T cells.

    abstract::Dendritic cells (DCs) are considered critical for the induction of graft-versus-host disease (GVHD) after bone marrow transplantation (BMT). In addition to their priming function, dendritic cells have been shown to induce organ-tropism through induction of specific homing molecules on T cells. Using adoptive transfer ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-06-096602

    authors: Kim TD,Terwey TH,Zakrzewski JL,Suh D,Kochman AA,Chen ME,King CG,Borsotti C,Grubin J,Smith OM,Heller G,Liu C,Murphy GF,Alpdogan O,van den Brink MR

    更新日期:2008-03-01 00:00:00